Prosci, Inc.

Poway, CA 92064

SBIR Award Summary

Total Number of Awards 9
Total Value of Awards $2.53MM
First Award Date 01/18/01
Most Recent Award Date 07/01/15

Key Personnel

Last Name Name Awards Contact
Geng Yu Geng 9

9 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 07/01/15 - 06/30/16
PI: Yu Geng

DESCRIPTION: HIV-1/AIDS remains a serious public health problem globally with an estimated 7,000 new infections each day. An effective HIV-1 vaccine will be necessary for the long-term control of the HIV-1 pandemic. The goal of this study is to develop a safe and effective vaccine to prevent HIV-1 acquisition and transmission. Several potent and...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 07/01/14 - 06/30/15
PI: Yu Geng

DESCRIPTION: HIV-1/AIDS remains a serious public health problem globally with an estimated 7,000 new infections each day. An effective HIV-1 vaccine will be necessary for the long-term control of the HIV-1 pandemic. The goal of this study is to develop a safe and effective vaccine to prevent HIV-1 acquisition and transmission. Several potent and...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 02/01/09 - 12/31/10
PI: Yu Geng

DESCRIPTION (provided by applicant): Although humoral immunity is a critical component in an effective HIV/AIDS vaccine to control the rampant spread of HIV-1, few of the vaccine candidates currently in preclinical and clinical trials appear to elicit broadly neutralizing antibodies. Several lines of evidences show that high mannose type carbohy...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-34
Budget: 02/01/08 - 01/31/09
PI: Yu Geng

DESCRIPTION (provided by applicant): Although humoral immunity is a critical component in an effective HIV/AIDS vaccine to control the rampant spread of HIV-1, few of the vaccine candidates currently in preclinical and clinical trials appear to elicit broadly neutralizing antibodies. Several lines of evidences show that high mannose type carbohy...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-27
Budget: 05/01/07 - 04/30/08
PI: Yu Geng

DESCRIPTION (provided by applicant): Eliciting broadly neutralizing antibodies to prevent HIV-1 infection from a large diversity of primary isolates is a top priority in the development of an effective HIV/AIDS vaccine. Several MAbs isolated from HIV infected humans including lgG1b12, 2G12, 2F5 and 4E10 have broad neutralizing activity, but such...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-27
Budget: 05/01/06 - 04/30/07
PI: Yu Geng

DESCRIPTION (provided by applicant): Eliciting broadly neutralizing antibodies to prevent HIV-1 infection from a large diversity of primary isolates is a top priority in the development of an effective HIV/AIDS vaccine. Several MAbs isolated from HIV infected humans including lgG1b12, 2G12, 2F5 and 4E10 have broad neutralizing activity, but such...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/03 - 05/31/05
PI: Yu Geng

DESCRIPTION: (Provided by Applicant) Development of a safe and effective AIDS vaccine has tremendous commercial potential and social impact and is a national priority. In response to the obstacles presented in AIDS vaccine development, a set of new concepts and designs is integrated to develop a new AIDS vaccine...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/02 - 05/31/03
PI: Yu Geng

DESCRIPTION: (Provided by Applicant) Development of a safe and effective AIDS vaccine has tremendous commercial potential and social impact and is a national priority. In response to the obstacles presented in AIDS vaccine development, a set of new concepts and designs is integrated to develop a new AIDS vaccine...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/18/01 - 12/31/01
PI: Yu Geng

DESCRIPTION: Cancer remains the second leading cause of death in developed countries. A cancer-associated protein was recently discovered during evaluation of antibodies. This protein, like telomerase, was abundantly expressed in 85 percent of tumor cell lines and malignant tumor tissues from patient...